USPTO serial 79336645
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Angela P. Doughty
Angela P. Doughty Ward and Smith, P.A.751 Corporate Center Drive, Suite 300Post Office Box 33009Raleigh, NC 27636-3009| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diagnostic preparations for medical and veterinary purposes; diagnostic biomarker reagents for medical or veterinary purposes; preparations for detecting genetic predispositions for medical or veterinary purposes; reagents for medical use for determining a metabolome, in particular a metabolome in the event of a disease; nucleic acid sequences for medical and veterinary purposes; metabolites for medical use and for veterinary purposes in the nature of lipids, amino acids, and steroids | ACTIVE | — |
| 035 | Collating and systematic ordering of data in a computer database, namely, systemization of data into computer databases; computerized file management; data search in computer files for others, namely, searching and reviewing data pulled from the computer files of others and annotating such data on behalf of others for business purposes; compilation of statistical data relating to medical research for business purposes; compilation of statistical data for use in scientific research for business purposes | ACTIVE | — |
| 042 | Scientific and technological services, namely quality control of the metabolic measurement, univariate and multivariate statistical analysis for feature extraction, discovery of metabolic biomarkers, training of supervised machine learning models on metabolic data, annotation of spectral features with chemical structures, stratification of samples based on pathologic genetic variants, gender, sample origin, patient age, medication; industrial analysis and research services in the field of biotechnology, namely, discovery of biomarker and stratification of samples based on pathologic genetic variants, gender, sample origin, patient age, medication; research and development services, in relation to biotechnology, pharmacology, metabolomics; genetic engineering services; research and development in the field of medical diagnostics; design, development, programming and implementation of software and computerized databases; computerised scientific research, testing and analysis; design and development of computer hardware; software as a service featuring software for quality control of the metabolic measurement, univariate and multivariate statistical analysis for feature extraction, discovery of metabolic biomarkers, training of supervised machine learning models on metabolic data, annotation of spectral features with chemical structures, stratification of samples based on pathologic genetic variants, gender, sample origin, patient age, medication; rental of computer software for data processing; software as a service (SaaS) featuring software for quality control of the metabolic measurement, univariate and multivariate statistical analysis for feature extraction, discovery of metabolic biomarkers, training of supervised machine learning models on metabolic data, annotation of spectral features with chemical structures, stratification of samples based on pathologic genetic variants, gender, sample origin, patient age, medication in the field of metabolome; provision of information, in relation to pharmacology, metabolomics | ACTIVE | — |
| 044 | Conducting of medical tests for diagnostic or treatment purposes; medical testing to determine the metabolome in an organism; medical testing for supporting the methods of diagnostic and treatment purposes to determine the metabolome in an organism; medical services in the fields of DNA sequencing for diagnostic purposes, genetic science, genetic testing, and metabolomics; medical analysis in connection with the treatment of individuals in relation to metabolism and metabolomics; medical analysis services for research purposes provided by medical laboratories for the analysis of samples taken from patients; providing of information in the fields of medicine and veterinary medicine; provision of information, in relation to metabolism and metabolomics; medical information | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 10, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 15, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 15, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 13, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 13, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 13, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 28, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 28, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 8, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 22, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 16, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 16, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 16, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 12, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 20, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 20, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 27, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 26, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 20, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 29, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 25, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 24, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |